Information between 1st March 2025 - 11th March 2025
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
| Division Votes |
|---|
|
4 Mar 2025 - Border Security, Asylum and Immigration Bill (Third sitting) - View Vote Context Susan Murray voted No - in line with the party majority and in line with the House One of 1 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 3 Noes - 12 |
|
4 Mar 2025 - Border Security, Asylum and Immigration Bill (Third sitting) - View Vote Context Susan Murray voted No - in line with the party majority and in line with the House One of 1 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 3 Noes - 12 |
|
4 Mar 2025 - Border Security, Asylum and Immigration Bill (Third sitting) - View Vote Context Susan Murray voted No - in line with the party majority and in line with the House One of 1 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 3 Noes - 12 |
|
4 Mar 2025 - Border Security, Asylum and Immigration Bill (Third sitting) - View Vote Context Susan Murray voted No - in line with the party majority and in line with the House One of 1 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 3 Noes - 12 |
|
3 Mar 2025 - Finance Bill - View Vote Context Susan Murray voted No - in line with the party majority and against the House One of 60 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 339 Noes - 172 |
|
3 Mar 2025 - Finance Bill - View Vote Context Susan Murray voted Aye - in line with the party majority and against the House One of 59 Liberal Democrat Aye votes vs 0 Liberal Democrat No votes Tally: Ayes - 167 Noes - 347 |
|
3 Mar 2025 - Finance Bill - View Vote Context Susan Murray was Teller for the Ayes and against the House Tally: Ayes - 176 Noes - 332 |
|
6 Mar 2025 - Border Security, Asylum and Immigration Bill (Fifth sitting) - View Vote Context Susan Murray voted No - in line with the party majority and in line with the House One of 2 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 3 Noes - 13 |
|
6 Mar 2025 - Border Security, Asylum and Immigration Bill (Fifth sitting) - View Vote Context Susan Murray voted No - in line with the party majority and in line with the House One of 2 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 3 Noes - 13 |
|
6 Mar 2025 - Border Security, Asylum and Immigration Bill (Fifth sitting) - View Vote Context Susan Murray voted No - in line with the party majority and in line with the House One of 2 Liberal Democrat No votes vs 0 Liberal Democrat Aye votes Tally: Ayes - 3 Noes - 13 |
| Speeches |
|---|
|
Susan Murray speeches from: Oral Answers to Questions
Susan Murray contributed 2 speeches (149 words) Wednesday 5th March 2025 - Commons Chamber Cabinet Office |
|
Susan Murray speeches from: Border Security, Asylum and Immigration Bill (Third sitting)
Susan Murray contributed 3 speeches (152 words) Committee stage: 3rd sitting Tuesday 4th March 2025 - Public Bill Committees Home Office |
| Written Answers |
|---|
|
Electronic Cigarettes: Packaging
Asked by: Susan Murray (Liberal Democrat - Mid Dunbartonshire) Wednesday 5th March 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to regulate the packaging of vapes to provide similar safeguards to that of cigarettes. Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care) It is very worrying that approximately 25% of 11 to 15-year-olds have tried vaping, despite the risks of nicotine addiction. Evidence suggests that vapes appeal to children because of the brightly coloured packaging, amongst other child-friendly features. Evidence also indicates that the nicotine content descriptions on vape packaging are not consistent between packaging, preventing adults from making informed decisions on nicotine strength. The Tobacco and Vapes Bill provides my Rt Hon. Friend, the Secretary of State for Health and Social Care with regulation-making powers to introduce new requirements on retail packaging, including for vaping products and nicotine products. There is a balance to be struck between reducing the appeal of vapes to non-smokers, particularly children, whilst considering the implications for adult smokers to ensure we can achieve the greatest possible impact. It is our intention to regulate the appeal of vapes to children, whilst minimising the impact on adult smokers. We plan on consulting on the preferred options to get this balance right as soon as possible after the bill gains Royal Assent. |
|
Pancreatic Enzyme Replacement Therapy: Shortages
Asked by: Susan Murray (Liberal Democrat - Mid Dunbartonshire) Monday 10th March 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether he plans to meet (a) clinicians, (b) patient advocacy groups, (c) affected charities and (d) manufacturers of pancreatic enzyme replacement therapy to discuss (i) shortages and (ii) potential steps to increase supply. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) The Department monitors and manages medicine supply issues at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within individual National Health Service trusts is not held centrally. The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to mitigate the supply issue that is affecting the whole of the United Kingdom. Through this, we have managed to secure additional volumes of PERT for 2025 for the UK. We are continuing to work with all suppliers to understand what more can be done to add further resilience to the market. The Department has also reached out to specialist importers who have sourced unlicensed stock to assist in covering the remaining gap in the market. In the longer term, the Department has had interest from non-UK suppliers wishing to bring their products to the UK and, along with colleagues in the Medicine and Healthcare products Regulatory Agency, we are working with these potential suppliers, and if authorised, these products could further diversify and strengthen the market. In December 2024, the Department issued further management advice to healthcare professionals. This directs clinicians to consider the unlicensed imports when licensed stock is unavailable and includes actions for integrated care boards to ensure local mitigation plans are put in place and implemented. The Department continues to collaborate closely with NHS England colleagues, clinicians, patient groups, and charities to ensure that these mitigation plans are supporting patients, and routinely updates advice and issues further guidance when necessary. There are no current plans to provide additional funding for unlicensed imports. The Department will continue to meet with suppliers, clinicians, representatives from the impacted patient advocacy groups, and charities so that they are informed on the supply situation and the mitigation actions being taken. |
|
Pancreatic Enzyme Replacement Therapy: Shortages
Asked by: Susan Murray (Liberal Democrat - Mid Dunbartonshire) Monday 10th March 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of local plans implemented by Integrated Care Boards to mitigate pancreatic enzyme replacement therapy shortages. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) The Department monitors and manages medicine supply issues at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within individual National Health Service trusts is not held centrally. The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to mitigate the supply issue that is affecting the whole of the United Kingdom. Through this, we have managed to secure additional volumes of PERT for 2025 for the UK. We are continuing to work with all suppliers to understand what more can be done to add further resilience to the market. The Department has also reached out to specialist importers who have sourced unlicensed stock to assist in covering the remaining gap in the market. In the longer term, the Department has had interest from non-UK suppliers wishing to bring their products to the UK and, along with colleagues in the Medicine and Healthcare products Regulatory Agency, we are working with these potential suppliers, and if authorised, these products could further diversify and strengthen the market. In December 2024, the Department issued further management advice to healthcare professionals. This directs clinicians to consider the unlicensed imports when licensed stock is unavailable and includes actions for integrated care boards to ensure local mitigation plans are put in place and implemented. The Department continues to collaborate closely with NHS England colleagues, clinicians, patient groups, and charities to ensure that these mitigation plans are supporting patients, and routinely updates advice and issues further guidance when necessary. There are no current plans to provide additional funding for unlicensed imports. The Department will continue to meet with suppliers, clinicians, representatives from the impacted patient advocacy groups, and charities so that they are informed on the supply situation and the mitigation actions being taken. |
|
Pancreatic Enzyme Replacement Therapy
Asked by: Susan Murray (Liberal Democrat - Mid Dunbartonshire) Monday 10th March 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether his Department plans to provide additional funding to Integrated Care Boards for the importation of alternative pancreatic enzyme replacement therapy brands. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) The Department monitors and manages medicine supply issues at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within individual National Health Service trusts is not held centrally. The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to mitigate the supply issue that is affecting the whole of the United Kingdom. Through this, we have managed to secure additional volumes of PERT for 2025 for the UK. We are continuing to work with all suppliers to understand what more can be done to add further resilience to the market. The Department has also reached out to specialist importers who have sourced unlicensed stock to assist in covering the remaining gap in the market. In the longer term, the Department has had interest from non-UK suppliers wishing to bring their products to the UK and, along with colleagues in the Medicine and Healthcare products Regulatory Agency, we are working with these potential suppliers, and if authorised, these products could further diversify and strengthen the market. In December 2024, the Department issued further management advice to healthcare professionals. This directs clinicians to consider the unlicensed imports when licensed stock is unavailable and includes actions for integrated care boards to ensure local mitigation plans are put in place and implemented. The Department continues to collaborate closely with NHS England colleagues, clinicians, patient groups, and charities to ensure that these mitigation plans are supporting patients, and routinely updates advice and issues further guidance when necessary. There are no current plans to provide additional funding for unlicensed imports. The Department will continue to meet with suppliers, clinicians, representatives from the impacted patient advocacy groups, and charities so that they are informed on the supply situation and the mitigation actions being taken. |
|
Pancreatic Enzyme Replacement Therapy
Asked by: Susan Murray (Liberal Democrat - Mid Dunbartonshire) Monday 10th March 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to diversify the supply chain for pancreatic enzyme replacement therapy. Answered by Karin Smyth - Minister of State (Department of Health and Social Care) The Department monitors and manages medicine supply issues at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within individual National Health Service trusts is not held centrally. The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to mitigate the supply issue that is affecting the whole of the United Kingdom. Through this, we have managed to secure additional volumes of PERT for 2025 for the UK. We are continuing to work with all suppliers to understand what more can be done to add further resilience to the market. The Department has also reached out to specialist importers who have sourced unlicensed stock to assist in covering the remaining gap in the market. In the longer term, the Department has had interest from non-UK suppliers wishing to bring their products to the UK and, along with colleagues in the Medicine and Healthcare products Regulatory Agency, we are working with these potential suppliers, and if authorised, these products could further diversify and strengthen the market. In December 2024, the Department issued further management advice to healthcare professionals. This directs clinicians to consider the unlicensed imports when licensed stock is unavailable and includes actions for integrated care boards to ensure local mitigation plans are put in place and implemented. The Department continues to collaborate closely with NHS England colleagues, clinicians, patient groups, and charities to ensure that these mitigation plans are supporting patients, and routinely updates advice and issues further guidance when necessary. There are no current plans to provide additional funding for unlicensed imports. The Department will continue to meet with suppliers, clinicians, representatives from the impacted patient advocacy groups, and charities so that they are informed on the supply situation and the mitigation actions being taken. |
| Early Day Motions |
|---|
|
Thursday 6th March Recognition of Milngavie in Bloom 17 signatures (Most recent: 11 Mar 2025)Tabled by: Susan Murray (Liberal Democrat - Mid Dunbartonshire) That this House recognises the valuable work of Milngavie in Bloom for improving the environment of the local community of Milngavie; thanks them for 17 years of continued service; notes their particular work in looking after the planters in the town centre, the flowerbeds across town, the verges and green … |
| Early Day Motions Signed |
|---|
|
Monday 10th March Susan Murray signed this EDM on Wednesday 12th March 2025 59 signatures (Most recent: 25 Mar 2025) Tabled by: Helen Morgan (Liberal Democrat - North Shropshire) That this House notes the perilous state of community pharmacies, which are struggling to survive across the country; recognises that pharmacies are at the heart of our communities, are an essential part of health and care services, and are relied upon by millions of people every day; further notes that … |
|
Wednesday 5th March Susan Murray signed this EDM on Wednesday 12th March 2025 South West Blood Bikes' volunteers 13 signatures (Most recent: 12 Mar 2025)Tabled by: Steve Darling (Liberal Democrat - Torbay) That this House celebrates the work of South West Blood Bikes as they complete their 350th delivery in support of Torbay and South Devon NHS Foundation Trust; recognises the vital role of their dedicated volunteers in providing this free emergency courier service across Devon, ensuring the timely transport of blood, … |
|
Tuesday 4th March Susan Murray signed this EDM on Tuesday 11th March 2025 Impact Assessments of changes to Official Development Assistance 34 signatures (Most recent: 19 Mar 2025)Tabled by: Monica Harding (Liberal Democrat - Esher and Walton) That an Humble Address be presented to His Majesty, that he will be graciously pleased to give directions that there be deposited in the House of Commons Library all impact assessments which His Majesty’s Government have made regarding the impact of the reduction of Official Development Assistance from 0.5% to … |
|
Wednesday 26th February Susan Murray signed this EDM on Tuesday 11th March 2025 45 signatures (Most recent: 24 Mar 2025) Tabled by: Calum Miller (Liberal Democrat - Bicester and Woodstock) That this House is deeply concerned by recent developments in the West Bank; believes that the deployment of Israeli military personnel to the West Bank, which constitutes one of the most significant military operations in the area since 2002, further escalates tensions and undermines the stability of the fragile ceasefires … |
|
Thursday 6th March Susan Murray signed this EDM as a sponsor on Friday 7th March 2025 39 signatures (Most recent: 19 Mar 2025) Tabled by: Pippa Heylings (Liberal Democrat - South Cambridgeshire) That this House notes with concern the increasing challenge of ensuring children’s safety online, which remains more important than ever; recognises the need to consider whether existing guidance on smartphone use in schools should be put on a legislative footing; acknowledges that such a measure aims to create an environment … |
| Select Committee Documents |
|---|
|
Wednesday 5th March 2025
Oral Evidence - Glasgow City Health and Social Care Partnership, NHS Greater Glasgow and Clyde, Glasgow City Council, and NHS Greater Glasgow and Clyde Problem drug use in Scotland follow-up: Glasgow’s Safer Drug Consumption Facility - Scottish Affairs Committee Found: : Patricia Ferguson (Chair); Maureen Burke; Stephen Flynn; Lillian Jones; Douglas McAllister; Susan Murray |
| Bill Documents |
|---|
|
Mar. 11 2025
Public Bill Committee Amendments as at 11 March 2025 Border Security, Asylum and Immigration Bill 2024-26 Amendment Paper Found: _9 Lisa Smart Susan Murray Mr Will Forster . |
|
Mar. 11 2025
Consideration of Bill Amendments as at 11 March 2025 - large print Employment Rights Bill 2024-26 Amendment Paper Found: Leishman Louise Haigh Andrew Cooper Dr Beccy Cooper Dame Siobhain McDonagh Julia Buckley Susan Murray |
|
Mar. 11 2025
Consideration of Bill Amendments as at 11 March 2025 Employment Rights Bill 2024-26 Amendment Paper Found: Leishman Louise Haigh Andrew Cooper Dr Beccy Cooper Dame Siobhain McDonagh Julia Buckley Susan Murray |
|
Mar. 10 2025
Notices of Amendments as at 10 March 2025 Border Security, Asylum and Immigration Bill 2024-26 Amendment Paper Found: _9 Lisa Smart Susan Murray Mr Will Forster . |
|
Mar. 10 2025
Notices of Amendments as at 10 March 2025 Employment Rights Bill 2024-26 Amendment Paper Found: Hobhouse Mr Lee Dillon Charlotte Nichols Sarah Dyke Steve Darling Anneliese Midgley Liz Jarvis Susan Murray |
|
Mar. 07 2025
Notices of Amendments as at 7 March 2025 Border Security, Asylum and Immigration Bill 2024-26 Amendment Paper Found: _9 Lisa Smart Susan Murray Mr Will Forster . |
|
Mar. 07 2025
Notices of Amendments as at 7 March 2025 Employment Rights Bill 2024-26 Amendment Paper Found: Hinchliff Abtisam Mohamed Iqbal Mohamed Jon Trickett Ellie Chowns Mr James Frith Shockat Adam Susan Murray |
|
Mar. 06 2025
Public Bill Committee Amendments as at 6 March 2025 Border Security, Asylum and Immigration Bill 2024-26 Amendment Paper Found: _NC6 Lisa Smart Susan Murray Mr Will Forster . |
|
Mar. 06 2025
Notices of Amendments as at 6 March 2025 Employment Rights Bill 2024-26 Amendment Paper Found: Hinchliff Abtisam Mohamed Iqbal Mohamed Jon Trickett Ellie Chowns Mr James Frith Shockat Adam Susan Murray |
|
Mar. 05 2025
Notices of Amendments as at 5 March 2025 Border Security, Asylum and Immigration Bill 2024-26 Amendment Paper Found: _9 Lisa Smart Susan Murray Mr Will Forster . |
|
Mar. 05 2025
Notices of Amendments as at 5 March 2025 Employment Rights Bill 2024-26 Amendment Paper Found: Hinchliff Abtisam Mohamed Iqbal Mohamed Jon Trickett Ellie Chowns Mr James Frith Shockat Adam Susan Murray |
|
Mar. 04 2025
Public Bill Committee Amendments as at 4 March 2025 Border Security, Asylum and Immigration Bill 2024-26 Amendment Paper Found: _9 Lisa Smart Susan Murray Mr Will Forster . |
|
Mar. 04 2025
Notices of Amendments as at 4 March 2025 Employment Rights Bill 2024-26 Amendment Paper Found: Hinchliff Abtisam Mohamed Iqbal Mohamed Jon Trickett Ellie Chowns Mr James Frith Shockat Adam Susan Murray |
| Calendar |
|---|
|
Wednesday 19th March 2025 9 a.m. Scottish Affairs Committee - Oral evidence Subject: GB Energy and the net zero transition At 9:30am: Oral evidence Robert Deavy - Scotland Senior Organiser at GMB Ian Perth - Negotiations Officer at Prospect Derek Thomson - Scotland Regional Secretary at Unite the Union View calendar - Add to calendar |
|
Wednesday 19th March 2025 9 a.m. Scottish Affairs Committee - Oral evidence Subject: GB Energy and the net zero transition View calendar - Add to calendar |
|
Tuesday 25th March 2025 2 p.m. Scottish Affairs Committee - Private Meeting View calendar - Add to calendar |
|
Tuesday 25th March 2025 2 p.m. Scottish Affairs Committee - Oral evidence Subject: The work of the department View calendar - Add to calendar |
|
Tuesday 25th March 2025 2 p.m. Scottish Affairs Committee - Oral evidence Subject: The work of the department At 2:30pm: Oral evidence Rt Hon Ian Murray MP - Secretary of State for Scotland at Scotland Office Kirsty McNeill MP - Parliamentary Under-Secretary of State at Scotland Office Laurence Rockey - Director at Scotland Office View calendar - Add to calendar |